HK2 gRNA (BRDN0001162236) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing HK2 gRNA (BRDN0001162236)

Articles
Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis. Liu W, Yu X, Zhou L, Li J, Li M, Li W, Gao F. Onco Targets Ther. 2020 Apr 16;13:3209-3221. doi: 10.2147/OTT.S243212. eCollection 2020. PubMed

If you have published an article using this material, please email us at to have your article added to this page.